Yuhan Corporation’s new drug for lung cancer, 5Approved by the US FDA…

I'll remember the people who died suffering from lung cancer.
A new drug came out of Korea. First U.S. FDA Approved for Korean Anti-cancer Drugs


유한양행 폐암 신약,
美 FDA 승인…
국산 항암제 최초

Yuhan Corporation’s new drug for lung cancer,
Approved by the US FDA…
The first domestically produced anticancer drug

https://naver.me/GpC0iGXg

Yuhan Corporation's Lung Cancer Drug 'LECLAZA' in combination with 'RYBREVANT' Receives First U.S. Food and Drug Administration Approval



유한양행 폐암치료제 '렉라자'와 '라이브레반트' 병용, 미국 식품의약국(FDA) 최초 승인 획득


https://www.thebionews.net/news/articleView.html?idxno=8021

Yuhan Corporation's Lung Cancer Drug 'LECLAZA' in combination with 'RYBREVANT' Receives First U.S. Food and Drug Administration

https://www.thebionews.net/news/articleView.html?idxno=8021

Yuhan Corporation's Lung Cancer Drug 'LECLAZA' in combination with 'RYBREVANT' Receives First U.S. Food and Drug Administration

https://www.prnewswire.com/news-releases/rybrevant-amivantamab-vmjw-plus-lazcluze-lazertinib-approved-in-the-us-as-a-first-line-chemotherapy-free-treatment-for-patients-with-egfr-mutated-advanced-lung-cancer-302226047.html

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) approved in the U.S. as a first-line chemotherapy-free treatment fo

https://naver.me/FK5pWVGo

유한양행, '렉라자' 美 FDA 허가 소식에 12%대 급등[핫스탁]